Memo Therapeutics AG is the older company (2012 vs 2019); Transcenta is the larger of the two.
Side-by-Side Comparison
| Metric | Memo Therapeutics AG | Transcenta |
|---|---|---|
| Founded | ||
| Founded | 2012 older | 2019 |
| Headquarters | ||
| Headquarters | Schlieren, Switzerland | Princeton, United States |
| Employees | ||
| Employees | 45 | 94 larger |
| Industry | ||
| Industry | Biotechnology | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series C | IPO |
| Total Funding | ||
| Total Funding | $99.80M | $178.74M |
| Funding Rounds | ||
| Funding Rounds | 7 | 5 |
| Services | ||
| Services | Development of therapeutic antibodies, Antibody isolation and identification, Clinical trials for BKPyV treatment, Antibody repertoire mining, Collaboration for oncology and virology medicines | Biological Product Development, Antibody Generation, Clinical Research, Biotechnology Manufacturing, Partnering and Licensing |
| Target Customers | ||
| Target Customers | Kidney transplant recipients, Patients with viral infections, Cancer patients, Healthcare providers, Research institutions | Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Research Institutions, Global Healthcare Industry |
| Taxonomy | ||
| Taxonomy | Antibody Discovery, Immune Repertoire Analysis, Innovator, Therapeutic Antibodies, Microfluidic Screening, High Throughput Analysis, Recombinant Technology, Antibody Libraries, CAR-T Screening, TCR-T Screening, Bi-specific Antibodies, Immunology, Pharmaceuticals, Immunotherapy | Biopharmaceutical, Antibody Biotherapeutics, Clinical Stage, Oncology, Bone Disorders, Kidney Disorders, Drug Discovery, R&D, Biomanufacturing, Translational Research, Process Development, Therapeutic Antibodies, Clinical Development, External Partnering, Mergers And Acquisitions |
| Website | ||
| Website | memo-therapeutics.com | transcenta.com |
About Memo Therapeutics AG
Memo Therapeutics AG (MTx), founded in 2012, is a promising late-stage biotech company situated in Switzerland. The company is dedicated to turning unique human immune responses into superior medicines. With a strong focus on biotechnology, MTx specializes in the development of best-in-class antibod...
About Transcenta
Transcenta, with the slogan INNOVATE TO EXCEL, is a clinical-stage biopharmaceutical company committed to the full integration of antibody-based biotherapeutics discovery, research, development, and manufacturing. Founded in 2019, Transcenta has made significant strides in the industry, solidifying...
We will tell you when either one moves
BounceWatch watches Memo Therapeutics AG and Transcenta for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Memo Therapeutics AG and Transcenta — by email.
Frequently Asked Questions
Compare Memo Therapeutics AG with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Memo Therapeutics AG on 15 Jun 2026, and Transcenta on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.